Skip to main content
Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
4.060
+0.240 (6.28%)
May 1, 2024, 3:13 PM EDT - Market open

Akoya Biosciences Revenue

In the year 2023, Akoya Biosciences had annual revenue of $96.63M with 29.09% growth. Revenue in the quarter ending December 31, 2023 was $26.49M with 24.83% year-over-year growth.

Revenue (ttm)
$96.63M
Revenue Growth
+29.09%
P/S Ratio
1.95
Revenue / Employee
$292,827
Employees
330
Market Cap
200.98M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202396.63M21.77M29.09%
Dec 31, 202274.86M19.94M36.31%
Dec 31, 202154.92M12.47M29.39%
Dec 31, 202042.44M207.00K0.49%
Dec 31, 201942.24M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alimera Sciences 80.75M
OptimizeRx 71.52M
Innate Pharma 68.49M
908 Devices 50.23M
Stereotaxis 26.77M
Century Therapeutics 2.24M
Revenue Rankings

AKYA News

More News